{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:20:33Z","timestamp":1790630433232,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T00:00:00Z","timestamp":1706918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T00:00:00Z","timestamp":1706918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81170472"],"award-info":[{"award-number":["81170472"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270139"],"award-info":[{"award-number":["82270139"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970115"],"award-info":[{"award-number":["81970115"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012612","name":"Tianjin Research Program of Application Foundation and Advanced Technology of China","doi-asserted-by":"publisher","award":["14JCYBJC27200"],"award-info":[{"award-number":["14JCYBJC27200"]}],"id":[{"id":"10.13039\/501100012612","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012612","name":"Tianjin Research Program of Application Foundation and Advanced Technology of China","doi-asserted-by":"publisher","award":["09JCYBJC11200"],"award-info":[{"award-number":["09JCYBJC11200"]}],"id":[{"id":"10.13039\/501100012612","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010041","name":"Tianjin Municipal Science and Technology Committee","doi-asserted-by":"publisher","award":["TJWJ2023QN006"],"award-info":[{"award-number":["TJWJ2023QN006"]}],"id":[{"id":"10.13039\/501100010041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["18ZXDBSY00140"],"award-info":[{"award-number":["18ZXDBSY00140"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Zhaoyicheng Medical Science Foundation of Tianjin China","award":["ZYYFY2018026"],"award-info":[{"award-number":["ZYYFY2018026"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s00277-024-05636-9","type":"journal-article","created":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T03:01:56Z","timestamp":1706929316000},"page":"1877-1885","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A nomogram model for predicting the efficacy of cyclosporine in patients with pure red cell aplasia"],"prefix":"10.1007","volume":"103","author":[{"given":"Liyan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyue","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuying","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2402-2717","authenticated-orcid":false,"given":"Huaquan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zonghong","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,3]]},"reference":[{"issue":"24","key":"5636_CR1","doi-asserted-by":"publisher","first-page":"6282","DOI":"10.1182\/bloodadvances.2021006486","volume":"6","author":"H Nakazawa","year":"2022","unstructured":"Nakazawa H, Sakai K, Ohta A et al (2022) Incidence of acquired pure red cell aplasia: a nationwide epidemiologic analysis with 2 registry databases in Japan. Blood Adv 6(24):6282\u20136290","journal-title":"Blood Adv"},{"issue":"2","key":"5636_CR2","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1073\/pnas.58.2.493","volume":"58","author":"SB Krantz","year":"1967","unstructured":"Krantz SB, Kao V (1967) Studies on red cell aplasia. I. Demonstration of a plasma inhibitor to heme synthesis and an antibody to erythroblast nuclei. Proc Natl Acad Sci USA 58(2):493\u2013500","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"5636_CR3","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1056\/NEJM199603073341004","volume":"334","author":"N Casadevall","year":"1996","unstructured":"Casadevall N, Dupuy E, Molho-Sabatier P, Tobelem G, Varet B, Mayeux P (1996) Autoantibodies against erythropoietin in a patient with pure red-cell aplasia. N Engl J Med 334(10):630\u2013633","journal-title":"N Engl J Med"},{"key":"5636_CR4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3389\/fcimb.2018.00166","volume":"8","author":"SS Ganaie","year":"2018","unstructured":"Ganaie SS, Qiu J (2018) Recent advances in replication and infection of human parvovirus B19. Front Cell Infect Microbiol 8:166","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"5636_CR5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.autrev.2015.09.005","volume":"15","author":"C Bernard","year":"2016","unstructured":"Bernard C, Frih H, Pasquet F et al (2016) Thymoma associated with autoimmune diseases: 85 cases and literature review. Autoimmun Rev 15(1):82\u201392","journal-title":"Autoimmun Rev"},{"key":"5636_CR6","doi-asserted-by":"publisher","first-page":"475313","DOI":"10.1100\/2012\/475313","volume":"2012","author":"E Vlachaki","year":"2012","unstructured":"Vlachaki E, Diamantidis MD, Klonizakis P, Haralambidou-Vranitsa S, Ioannidou-Papagiannaki E, Klonizakis I (2012) Pure red cell aplasia and lymphoproliferative disorders: an infrequent association. Sci World J 2012:475313","journal-title":"Sci World J"},{"key":"5636_CR7","doi-asserted-by":"publisher","first-page":"8229","DOI":"10.2147\/OTT.S222378","volume":"12","author":"ZY Qiu","year":"2019","unstructured":"Qiu ZY, Qin R, Tian GY, Wang Y, Zhang YQ (2019) Pathophysiologic mechanisms and management of large granular lymphocytic leukemia associated pure red cell aplasia. Onco Targets Ther 12:8229\u20138240","journal-title":"Onco Targets Ther"},{"issue":"6","key":"5636_CR8","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/bjh.12210","volume":"160","author":"FM Aung","year":"2013","unstructured":"Aung FM, Lichtiger B, Bassett R et al (2013) Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation. Br J Haematol 160(6):798\u2013805","journal-title":"Br J Haematol"},{"issue":"2","key":"5636_CR9","first-page":"e7112","volume":"12","author":"W Azhar","year":"2020","unstructured":"Azhar W, Zaidi F, Hannan A (2020) Isoniazid induced pure red blood cell aplasia. Cureus 12(2):e7112","journal-title":"Cureus"},{"issue":"Suppl 2","key":"5636_CR10","doi-asserted-by":"publisher","first-page":"S303","DOI":"10.1177\/089686080702702s52","volume":"27","author":"F Locatelli","year":"2007","unstructured":"Locatelli F, Del Vecchio L, Pozzoni P (2007) Pure red-cell aplasia \u201cepidemic\u201d\u2013mystery completely revealed. Perit Dial Int 27(Suppl 2):S303\u2013S307","journal-title":"Perit Dial Int"},{"issue":"3","key":"5636_CR11","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1093\/ndt\/gfu297","volume":"30","author":"IC Macdougall","year":"2015","unstructured":"Macdougall IC, Casadevall N, Locatelli F et al (2015) Incidence of erythropoietin antibody-mediated pure red cell aplasia: the Prospective Immunogenicity Surveillance Registry (PRIMS). Nephrol Dial Transplant 30(3):451\u2013460","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"5636_CR12","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1080\/16078454.2021.1929694","volume":"26","author":"H Wang","year":"2021","unstructured":"Wang H, Niu H, Zhang T, Xing L, Shao Z, Fu R (2021) Low- and intermediate-risk myelodysplastic syndrome with pure red cell aplasia. Hematology 26(1):444\u2013446","journal-title":"Hematology"},{"issue":"2","key":"5636_CR13","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3324\/haematol.2017.175810","volume":"103","author":"SK Balasubramanian","year":"2018","unstructured":"Balasubramanian SK, Sadaps M, Thota S et al (2018) Rational management approach to pure red cell aplasia. Haematologica 103(2):221\u2013230","journal-title":"Haematologica"},{"issue":"15","key":"5636_CR14","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1182\/blood.2021010898","volume":"137","author":"C Gurnari","year":"2021","unstructured":"Gurnari C, Maciejewski JP (2021) How I manage acquired pure red cell aplasia in adults. Blood 137(15):2001\u20132009","journal-title":"Blood"},{"issue":"4","key":"5636_CR15","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1365-2141.2008.07216.x","volume":"142","author":"K Sawada","year":"2008","unstructured":"Sawada K, Fujishima N, Hirokawa M (2008) Acquired pure red cell aplasia: updated review of treatment. Br J Haematol 142(4):505\u2013514","journal-title":"Br J Haematol"},{"issue":"6","key":"5636_CR16","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1111\/bjh.15245","volume":"184","author":"H Jiang","year":"2019","unstructured":"Jiang H, Zhang H, Wang Y et al (2019) Sirolimus for the treatment of multi-resistant pure red cell aplasia. Br J Haematol 184(6):1055\u20131058","journal-title":"Br J Haematol"},{"issue":"11","key":"5636_CR17","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1007\/s00277-018-3431-5","volume":"97","author":"Z Long","year":"2018","unstructured":"Long Z, Yu F, Du Y et al (2018) Successful treatment of refractory\/relapsed acquired pure red cell aplasia with sirolimus. Ann Hematol 97(11):2047\u20132054","journal-title":"Ann Hematol"},{"issue":"9","key":"5636_CR18","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1080\/10245332.2018.1470068","volume":"23","author":"R Fu","year":"2018","unstructured":"Fu R, Zhang T, Liu B et al (2018) The clinical characteristics and therapy response of patients with acquired pure red cell aplasia. Hematology 23(9):639\u2013645","journal-title":"Hematology"},{"issue":"21","key":"5636_CR19","doi-asserted-by":"publisher","first-page":"6451","DOI":"10.1182\/bloodadvances.2023010587","volume":"7","author":"H Lobbes","year":"2023","unstructured":"Lobbes H, Lega JC, Le Guenno G, Ruivard M, Mainbourg S (2023) Treatment strategy for acquired pure red cell aplasia: a systematic review and meta-analysis. Blood Adv 7(21):6451\u20136465","journal-title":"Blood Adv"},{"key":"5636_CR20","unstructured":"Red Blood Cell Disease (Anemia) Group, Chinese Society of Hematology, Chinese Medical Association (2020) Chinese expert consensus on the diagnosis and treatment of acquired pure red cell aplasia. Zhonghua Xue Ye Xue Za Zhi 41(3):177\u2013184"},{"issue":"6","key":"5636_CR21","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/bjh.13376","volume":"169","author":"M Hirokawa","year":"2015","unstructured":"Hirokawa M, Sawada K, Fujishima N et al (2015) Long-term outcome of patients with acquired chronic pure red cell aplasia (PRCA) following immunosuppressive therapy: a final report of the nationwide cohort study in 2004\/2006 by the Japan PRCA collaborative study group. Br J Haematol 169(6):879\u2013886","journal-title":"Br J Haematol"},{"issue":"3","key":"5636_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s002770050151","volume":"72","author":"YL Kwong","year":"1996","unstructured":"Kwong YL, Wong KF, Liang RH, Chu YC, Chan LC, Chan TK (1996) Pure red cell aplasia: clinical features and treatment results in 16 cases. Ann Hematol 72(3):137\u2013140","journal-title":"Ann Hematol"},{"issue":"5","key":"5636_CR23","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s41375-022-01532-1","volume":"36","author":"Y Huang","year":"2022","unstructured":"Huang Y, Chen M, Yang C, Ruan J, Wang S, Han B (2022) Sirolimus is effective for refractory\/relapsed\/intolerant acquired pure red cell aplasia: results of a prospective single-institutional trial. Leukemia 36(5):1351\u20131360","journal-title":"Leukemia"},{"issue":"3","key":"5636_CR24","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00277-020-03926-6","volume":"99","author":"X Liu","year":"2020","unstructured":"Liu X, Lu X, Chen L et al (2020) Immunosuppressive therapy for elderly-acquired pure red cell aplasia: cyclosporine A may be more effective. Ann Hematol 99(3):443\u2013449","journal-title":"Ann Hematol"},{"issue":"1","key":"5636_CR25","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1093\/rheumatology\/keab363","volume":"61","author":"H Lobbes","year":"2021","unstructured":"Lobbes H, Mahevas M, Alviset S et al (2021) Pure red cell aplasia in systemic lupus erythematosus, a nationwide retrospective cohort and review of the literature. Rheumatology (Oxford) 61(1):355\u2013366","journal-title":"Rheumatology (Oxford)"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05636-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05636-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05636-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T06:05:40Z","timestamp":1715580340000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05636-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,3]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["5636"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05636-9","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,3]]},"assertion":[{"value":"5 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethical Committee of the Tianjin Medical University. Written informed consent was obtained from the patients for the publication of this report and any accompanying images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}